LCN2 and type 2 diabetes mellitus: Similarly, if lipocalin-2 was replaced by RBP4 in the model, RBP4 was independently associated with subclinical atherosclerosis in type 2 diabetes (OR 1.16, 95% CI 1.10–1.22, P<0.001).